Tang Capital Management »

Morphosys shares owned by Tang Capital Management

Quarter-by-quarter ownership of Morphosys (MOR) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Morphosys

Tip: Access up to 7 years of quarterly data

All positions including Morphosys held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Morphosys by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 801k 18.14

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Evolus (EOLS)
Kalvista Pharmaceuticals (KALV)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Altimmune Com New (ALT)
Immunocore Hldgs Ads (IMCR)
Inhibrx (INBX)
Eli Lilly & Co. (LLY)
Vaxcyte (PCVX)
Ptc Therapeutics I (PTCT)
Outlook Therapeutics
Rocket Pharmaceuticals (RCKT)
Immunome (IMNM)
Avadel Pharmaceuticals Sponsored Adr (AVDL)

View all positions for Tang Capital Management

Top funds holding Morphosys

Glazer Capital
Balyasny Asset Management
UBS Group
BlackRock
Tang Capital Management
Slotnik Capital
Goldman Sachs Group
Susquehanna International
Segantii Capital Management
Tudor Investment Corporation
Morgan Stanley
Marshall Wace
Centiva Capital
Schonfeld Strategic Advisors
Harvest Management

View all funds holding Morphosys